Company profile
Immunome Inc. Insider Trading
IMNMEvery SEC Form 4 insider trading filing for Immunome Inc. (IMNM) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001472012
- Filings
- 106
- Insiders
- 24
- Last filing
- 2026-08-12
Activity summary
Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares (net $1.1M). Buying was led by Horn Kinney.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Immunome Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $11.4M.
90 day insight
Over the last 90 days, Immunome Inc. insiders bought $2.1M across 32 transactions with no open-market sales.
- Most active insider: Barchas Isaac with 11 transactions totaling $9.9M.
- Largest single sale: $2.3M by Horn Kinney on Aug 4, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Barchas Isaac | IMNM | Sale10b5 | 11,048 | $27.25 | $301K |
| Aug 11, 2026 | Barchas Isaac | IMNM | Sale10b5 | 62,291 | $26.23 | $1.63M |
| Aug 10, 2026 | Barchas Isaac | IMNM | Sale10b5 | 10,125 | $26.07 | $264K |
| Aug 7, 2026 | Barchas Isaac | IMNM | Sale10b5 | 15,248 | $26.06 | $397K |
| Aug 6, 2026 | Barchas Isaac | IMNM | Sale10b5 | 20,840 | $26.06 | $543K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=IMNM" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Immunome Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →